Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Scrophularia nodosa
European hedgerow herb with cardiac and lymphatic properties used in traditional medicine for skin and glandular conditions.
Scrophularia nodosa, a European hedgerow herb, is traditionally used for lymphatic congestion, skin conditions, and glandular swelling. Its primary active compounds include harpagoside, aucubin, cinnamic acid, saponins, and flavonoids, which contribute to anti-inflammatory, mild cardiac tonic, and lymphatic-stimulating properties. Modern evidence is limited (Level C), supporting its use in inflammatory and lymphatic disorders, but clinical data remain sparse.
Harpagoside, an iridoid glycoside, exerts anti-inflammatory effects by inhibiting COX-2 and modulating NF-κB pathways, reducing prostaglandin and cytokine production. Aucubin and cinnamic acid derivatives provide additional anti-inflammatory and antimicrobial actions. Saponins and flavonoids may stimulate lymphatic flow and exhibit mild cardiotonic activity, possibly through weak digitalis-like receptor binding, though this mechanism is not fully elucidated and requires caution in patients on cardiac glycosides.
European hedgerow herb with cardiac and lymphatic properties used in traditional medicine for skin and glandular conditions.
Scrophularia nodosa, a European hedgerow herb, is traditionally used for lymphatic congestion, skin conditions, and glandular swelling. Its primary active compounds include harpagoside, aucubin, cinnamic acid, saponins, and flavonoids, which contribute to anti-inflammatory, mild cardiac tonic, and lymphatic-stimulating properties. Modern evidence is limited (Level C), supporting its use in inflammatory and lymphatic disorders, but clinical data remain sparse.
Harpagoside, an iridoid glycoside, exerts anti-inflammatory effects by inhibiting COX-2 and modulating NF-κB pathways, reducing prostaglandin and cytokine production. Aucubin and cinnamic acid derivatives provide additional anti-inflammatory and antimicrobial actions. Saponins and flavonoids may stimulate lymphatic flow and exhibit mild cardiotonic activity, possibly through weak digitalis-like receptor binding, though this mechanism is not fully elucidated and requires caution in patients on cardiac glycosides.